IT8719009A0 - Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. - Google Patents
Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.Info
- Publication number
- IT8719009A0 IT8719009A0 IT8719009A IT1900987A IT8719009A0 IT 8719009 A0 IT8719009 A0 IT 8719009A0 IT 8719009 A IT8719009 A IT 8719009A IT 1900987 A IT1900987 A IT 1900987A IT 8719009 A0 IT8719009 A0 IT 8719009A0
- Authority
- IT
- Italy
- Prior art keywords
- receptors
- procedure
- preparation
- antagonists
- compounds
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8719009A IT1215325B (it) | 1987-01-07 | 1987-01-07 | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
| KR1019870015139A KR880009004A (ko) | 1987-01-07 | 1987-12-27 | H_2-섭수체 길항제 화합물 |
| JP62336738A JPS6481A (en) | 1987-01-07 | 1987-12-28 | H2-receptor antagonist compound |
| EP88500002A EP0277900A3 (en) | 1987-01-07 | 1988-01-05 | H2-receptor antagonist compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8719009A IT1215325B (it) | 1987-01-07 | 1987-01-07 | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8719009A0 true IT8719009A0 (it) | 1987-01-07 |
| IT1215325B IT1215325B (it) | 1990-02-08 |
Family
ID=11153818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT8719009A IT1215325B (it) | 1987-01-07 | 1987-01-07 | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0277900A3 (it) |
| JP (1) | JPS6481A (it) |
| KR (1) | KR880009004A (it) |
| IT (1) | IT1215325B (it) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU591196B2 (en) * | 1985-11-15 | 1989-11-30 | Nippon Kayaku Kabushiki Kaisha | Novel forskolin derivatives |
| US4888595A (en) * | 1986-11-13 | 1989-12-19 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Acquisition signal transmitter |
| CH679582A5 (it) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4251449A (en) * | 1975-07-11 | 1981-02-17 | Clarence Schreur | Method of making a solid crystalline composition consisting essentially of calcium ascorbate |
| US4276219A (en) * | 1979-07-20 | 1981-06-30 | Pfizer Inc. | 5-Keto-L-ascorbic acid-5,5-dimethyl ketal, derivatives thereof and its use as an antioxidant and intermediate |
| EP0133493B1 (de) * | 1983-08-05 | 1989-01-25 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Verfahren zur Herstellung von Kohlenhydraten |
| CH674362A5 (en) * | 1986-08-05 | 1990-05-31 | Hasunor Ag | New ascorbate salts of H2 receptors antagonists |
-
1987
- 1987-01-07 IT IT8719009A patent/IT1215325B/it active
- 1987-12-27 KR KR1019870015139A patent/KR880009004A/ko not_active Application Discontinuation
- 1987-12-28 JP JP62336738A patent/JPS6481A/ja active Pending
-
1988
- 1988-01-05 EP EP88500002A patent/EP0277900A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6481A (en) | 1989-01-05 |
| KR880009004A (ko) | 1988-09-13 |
| EP0277900A2 (en) | 1988-08-10 |
| IT1215325B (it) | 1990-02-08 |
| EP0277900A3 (en) | 1989-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE82273T1 (de) | Leucotrien-antagonisten. | |
| MX11117A (es) | Procedimiento para la preparacion de nuevos antagonistas opioides de la piperidina. | |
| IT8320024A0 (it) | 1h-pirazolo [1,5-a] pirimidine sostituite e procedimento per la loro preparazione | |
| DK530888A (da) | Leukotrien -ltd4- og - ltb4-antagonister | |
| IT8423392A0 (it) | Cefem composti e procedimenti per la loro preparazione. | |
| IT8620297A0 (it) | Composti stabilizzanti eprocedimento per la loro preparazione. | |
| IT1240374B (it) | Composti polifluoroalchilici azotati, procedimento per la loro preparazione e loro impiego | |
| NO903513L (no) | Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister. | |
| IT8719009A0 (it) | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. | |
| IT9067657A0 (it) | Procedimento per la preparazione di alfa-alchil-lattoni. | |
| DE3875030D1 (de) | Leukotrien-antagonisten. | |
| IT1230584B (it) | Isopolipeptidi e procedimento per la loro preparazione | |
| IT1193604B (it) | 1,3,4-tiadiazolo (3,2-a) pirimidine sostituite e procedimento per la loro preparazione | |
| DK0418863T3 (da) | NMDA-antagonister | |
| IT8423805A0 (it) | Composti azabiciclici e procedimenti per la loro preparazione. | |
| IT1237501B (it) | Politiocarbonati e procedimento per la loro preparazione. | |
| MX9203754A (es) | Antagonistas de leucotrieno. | |
| IT1201442B (it) | Alchilsolfonipropeni,procedimento per la loro preparazione e loro impiego | |
| IT1210971B (it) | Composti biciclici eprocedimento per la loro preparazione. | |
| IT8723035A0 (it) | Procedimento per la preparazione di n acilaniline. | |
| DE69004827D1 (de) | Alpha-adrenergene Rezeptor-Antagonisten. | |
| IT8719073A0 (it) | Procedimento per la preparazione di omega-isopropossifenolo. | |
| IT9067138A1 (it) | Procedimento per la preparazione di alfa-alchil lattoni. | |
| IT8747852A0 (it) | Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
| NO853597L (no) | Preparat for tiltrekning av margborer. |